Navigation Links
BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
Date:4/5/2011

an "enriched" enrollment, double-blind, placebo-controlled, randomized withdrawal study measuring the efficacy and safety of BEMA Buprenorphine in patients with moderate to severe chronic pain.  Patients meeting the designated study criteria undergo titration with BEMA Buprenorphine to a dose that is both effective and well-tolerated.  Those patients who identify an effective and well tolerated dose are then randomized to either continue their BEMA Buprenorphine dose or begin use of a placebo (BEMA film with no active drug) for twelve weeks.  The primary efficacy measure is the mean change in pain intensity from the time patients are randomized (to BEMA Buprenorphine or placebo) through to the end of the twelve week study period.  The study design described has been utilized for a number of the opioid analgesics approved by the FDA in recent years.  The study design includes an interim analysis to confirm the number of patients needed for adequate statistical power.  This interim analysis is part of the study design agreed upon with FDA and is included solely to provide assurance that the sample size is adequate to detect the effect difference between the active and placebo treatments. 

About BioDelivery Sciences International

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.  BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and oncology supportive care.  BDSI's pain franchise currently consists of two products utilizing the patented BEMA technology.  ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada,
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
2. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
3. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
4. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
5. TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS SciFinder®
6. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
7. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
8. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
9. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
10. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
11. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 New high ... Medicare Part D by a projected $2.9 to $5.8 ... the actuarial firm Milliman released today by the Pharmaceutical ... D premiums could increase by as much as 8.6 ... C drugs, including Sovaldi and Olysio. The ...
(Date:7/29/2014)... ISPE—the International Society for Pharmaceutical Engineering ... as President and CEO, succeeding Nancy ... Society last fall.  Mr. Bournas takes the helm ... association industry as well as significant international experience.  ... for the expansion of its global initiatives and ...
(Date:7/29/2014)... LAUDERDALE, Fla. , July 29, 2014 /PRNewswire-iReach/ ... medical service provider, has launched its Medical ... Program.  These services are tailored to the ... excellent standards prompted industry operators to propose that ... MHG Medical,s new program is intended to ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2
... 7, 2011 BioSpecifics Technologies Corp. (Nasdaq: ... developing first in class collagenase-based products, today announced that ... (the "Rights Agreement"), adopted May 14, 2002 and previously ... Amendment increases the ownership threshold for determining "Acquiring Person" ...
... FRANCISCO, Feb. 7, 2011 Medivation, Inc. (Nasdaq: ... chief executive officer, will present at the 13th Annual BIO ... a.m. Eastern Time at the Waldorf-Astoria in New York. ... its clinical development programs for MDV3100 for prostate cancer and ...
Cached Medicine Technology:
(Date:7/29/2014)... recipients of living donor kidney transplants receive steady ... to be monitored. To make follow-up care more ... (Nasdaq: WAG) are collaborating to launch the first ... testing at no charge to living kidney donors. ... tests redeemable at more than 4,500 Walgreens pharmacies ...
(Date:7/29/2014)... A team of scientists, led by Western University ... a blood test for Alzheimer’s disease risk that may ... disease interventions, according to an article published July 29, ... study represents one of several pieces that have locked ... years,” Ethell said. , The study, “Women with the ...
(Date:7/29/2014)... Beach, Florida (PRWEB) July 29, 2014 Child ... scholarship for law students this week. The scholarship will help ... abused children and their families. , Steinger, Iscoe and Greene ... abuse, and want tomorrow’s attorneys to do the same. More ... each year according to the nonprofit Childhelp (retrieved ...
(Date:7/29/2014)... The report, “Heat Transfer Fluids Market by Type (Mineral ... Others), by Application (Oil & Gas, Chemical, CSP, Manufacturing ... Forecasts to 2019” defines and segments the global heat ... the global consumption in terms of volume and value. ... through 199 page sand in-depth TOC on"Heat Transfer Fluids ...
(Date:7/29/2014)... A new 3-part video series: The Cost/Benefit of ... Angiography and Interventions (SCAI) Scientific Sessions in Las Vegas, ... the benefits of ACE accreditation and the cost/benefit of ... from the perspective of clinicians who have worked with ... RN, Director of Cardiac and Interventional Services at Baptist ...
Breaking Medicine News(10 mins):Health News:Caring for donors 2Health News:Caring for donors 3Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Steinger, Iscoe & Greene Offers Child Advocate Scholarship 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 4Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3
... Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (NYSE ... the development of Computer-Aided Detection (CAD) and image analysis software ... pleased to announce the launch of its online product, MedicRead(TM) ... ColonCAD software truly accessible to all radiologists for the first ...
... June 29 Prometheus Laboratories Inc., a specialty ... of MyCeliacID(TM), the first do it yourself, saliva-based ... distinct genetic sequences associated with celiac disease, a ... million people in the United States. MyCeliacID is ...
... to hit market in September , , BOSTON, June 29 ... Times bestselling author and renowned wellness coach from NBC,s ... of weight-loss products in partnership with ThinCare(TM) International, LLC. The new ... Drug Stores Marketplace in Boston, Massachusetts on June 29, 2009. Scientifically ...
... ... your water supply. EcoloBlue 28 Atmospheric Water Generators provide pure drinking water from the humidity ... ... -- A person can survive only a short time without safe drinking water. In a ...
... ... Health Concerto™ portal to access critical health data stored in electronic health records (EHRs). The ... financial year. , ... Zealand (PRWEB) June 29, 2009 -- Orion Health , a market leader in providing ...
... SINGAPORE, June 29 /PRNewswire-Asia/ -- Rising healthcare ... will keep the,Asian market for medical tourism buoyant, according ... today at Fairmont Hotel, Singapore.,Worldwide gross medical tourism revenue ... billion by 2012, with Asia as a major driver ...
Cached Medicine News:Health News:Medicsight Launches ColonCAD(TM) Online CTC Platform 2Health News:Medicsight Launches ColonCAD(TM) Online CTC Platform 3Health News:Prometheus Launches MyCeliacID(TM), the First Do it Yourself, Saliva-Based Genetic Test Dedicated to Celiac Disease 2Health News:Prometheus Launches MyCeliacID(TM), the First Do it Yourself, Saliva-Based Genetic Test Dedicated to Celiac Disease 3Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 2Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 3Health News:EcoloBlue Atmospheric Water Generators(AWG) Will Provide Pure Drinking Water Following a Natural Disaster. 2Health News:Expanding into New Markets with Customer-Focused Solutions, Orion Health Sees Strong Growth 2Health News:Expanding into New Markets with Customer-Focused Solutions, Orion Health Sees Strong Growth 3Health News:Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012 2Health News:Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012 3
Shandon Paraffin Block Cartons...
... A histological embedment block ... This file system incorporates ... embedment block protection, simplified ... error and facilitation of ...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Medicine Products: